Study Group: Bosentan Prescribers for PAH (US)(?)
Council Members in this Study Group: 80
Request a survey with this Study Group
Leading Experts in this Study Group
Ass. Professor in Medicine
University of North Carolina at Chapel Hill School of Medicine - CC
Ray Coakley, MD PhD, is a physician scientist / pulmonary & critical care specialist at the University of North Carolina, Chapel Hill. His clinical and research focus is on COPD, cystic fibrosis, lung transplantation and PAH. Specific research expertise includes airway epithelial ion/fluid transport...
Herbert Baraf, MD, FACP, FACRClinical Associate Professor of Medicine
UNIVERSITY OF MARYLAND
Herbert Baraf, MD, FACP, FACR, is the Managing Partner of Arthritis and Rheumatism Associates and the Medical Director of Center for Rheumatology and Bone Research in Maryland. He is also the Clinical Professor of Medicine at George Washington University Medical Center and Clinical Associate Professor...
Robert Aris, MDAssociate Professor of Medicine
University of North Carolina Chapel Hill - CC
Robert Aris, MD, is an Associate Professor of Medicine at the University of North Carolina Chapel Hill. He is the Director of the Pulmonary Hypertension Program, the Lung Transplant Research Program and Inpatient Pulmonary Services. Dr. Aris has expertise in advanced lung diseases including cystic...
President
PSS Clinical Research
Warren Botnick, MD, FCCP, DABSM, is a Partner at Pulmonary and Sleep Specialists in Decatur, Georgia, since March 2003. He is Director of Critical Care Unit and Chief of Medicine at DeKalb Medical Center, Medical Director of Southern Sleep Technologies, and Co-Director of two sleep disorders centers...
Robyn Barst, MDFormerDirector
New York- Presbyterian/Columbia University Medical Center
Robyn J Barst, MD is Professor Emeritus of Pediatrics (in Medicine) at the College of Physicians and Surgeons at Columbia University. She was Director of the New York-Presbyterian Pulmonary Hypertension Center 1982-2008. She is a Fellow of the American Academy of Pediatrics, American College of Cardiology,...
Victor Tapson, MDMedical Director of Pulmonary Hypertension Center
Duke University
Victor Tapson, MD, is Professor of Medicine in the Division of Pulmonary and Critical Care at Duke University School of Medicine and the Medical Director of the Duke Pulmonary Hypertension Center. Dr. Tapson was Director for the Duke Lung Transplant Program for over 10 years and Director for the Center...
Assistant Professor & Director
University of Florida
Kamal Mubarak, MD, is an Assistant Professor and Director of the Pulmonary Vascular Disease Program at University of Florida, Gainesville. Dr. Mubarak's clinical specialties include Internal Medicine, Critical Care Medicine, and Pulmonary Disease. He is involved in numerous clinical trials in treating...
Inder Anand, MD, FACC, FRCP, DPhilDirector of the Heart Failure Program
Minneapolis VA Medical Center
Inder Anand, MD, FACC, FRCP, DPhil, is Professor of Medicine at the University of Minnesota. Dr. Anand is also Director of the Heart Failure Program at the Minneapolis VA Medical Center. Dr. Anand has expertise in pathophysiology and management of heart failure. He has been a principal investigator...
Related Study Groups
GLG NewsSMAnalyses by this Study Group's Leading Experts(?)
This phase III study was done without the benefit of conventional drug development with Phase I and Phase II studies (which would have provided more information about the effective dose) preceding it because pharmacokinetic date from IV and SC dosing studies were used to extrapolate for the...
While functional class II (FC II) PAH patients have been included in previous clinical trials, the EARLY trial is the first study to concentrate (ie recruit exclusively) FC II PAH patients. This is important because the definition of functional class II is that a patient has a sight...
This Circulation paper is the first peer reviewed data on the 2 pivotal Phase III trials on ambrisentan that lead the FDA to approving it for the treatment of PAH in July 2007. This paper is critically important since all new research needs to withstand the rigor of peer-review for...
Mechanical thrombectomy of the coronary arteries has becoming increasingly more common with the advent of simpler aspiration catheters. Although its use in the setting of acute myocardial infarction is even more common, it is not routine. Randomized data indicating its effect on clinical...
Novartis was able to show that combining tekturna with HCTZ provided significant improvement in blood pressure and did so safely. They also showed that it provides better 24 hour coverage and coverage if patients miss a dose or take it late, this is a significant improvement over its competitors...
Most Common Company Types:
- Academic Medical Center/Hospital or Clinic
- Office Based Private Practice or Clinic
- Non-Academic Community Hospital or Clinic
- Academic Institution*
Most Common Job Types:
- Physician - Attending Physician
- Physician - Director
- Physician - Division Head
- Partner
- President
- Owner
- Director
GLG's 750+ Clients Include:
global mutual funds
global banks
private equity firms

